Bladder drug may speed up recovery after prostate surgery
NCT ID NCT06966778
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether oxybutynin, a medication used for overactive bladder, can help men recover urinary control sooner after robotic prostate removal for prostate cancer. About 135 participants will take either the drug or a placebo daily for up to 3 months. Researchers will track how many men achieve continence (using 0-1 pads per day) within 12 months after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Taiwan University Hospital
RECRUITINGTaipei, 100, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can sound waves offer a lasting fix for prostate problems?
- A sharper eye on prostate cancer: could new imaging spare healthy tissue?
- Could a smartwatch and remote coaching cut incontinence after prostate surgery?
- Could a placental wrap help men recover erections faster after prostate cancer surgery?
- AI model may forecast prostate cancer recurrence after surgery
- Hormone shot timing may affect recovery after prostate cancer treatment